APP is central to the formation of amyloid plaques, which are characteristic of Alzheimer's disease. The accumulation of beta-amyloid peptides formed through the amyloidogenic pathway leads to plaque formation, neuronal damage, and cognitive decline. Understanding the regulation and processing of APP is therefore crucial for developing therapeutic strategies against Alzheimer's disease.
